What is the latest price of Avelumab in 2024?

Avelumab (Avelumab) is an injection that is injected intravenously (into the vein) for 60 minutes by a doctor or nurse in a medical institution or infusion center. It is usually given once every 2 weeks. The doctor will decide the frequency of Avelumab treatment based on the patient's body's response to this drug. Avelumab belongs to a class of drugs called monoclonal antibodies, which work by helping the body slow or stop the growth of cancer cells.

Avelumab is used to treat Merkel cell carcinoma (MCC; a type of skin cancer) that has spread to other parts of the body in adults and children over 12 years of age; also used to treat people who are receiving platinum-based chemotherapy drugs during or for 12 months after treatment Urothelial cancer (cancer in the lining of the bladder and other parts of the urethra) in people whose cancer has progressed and the cancer has spread to nearby tissue or other parts of the body; also used as an ongoing treatment for urothelial cancer that has spread to nearby tissue or other parts of the body, to help maintain response to platinum chemotherapy. Avelumab injection is also used in combination with axitinib in patients with renal cell carcinoma (RCC), a cancer that starts in the kidneys, that has spread or cannot be removed with surgery.

Avelumab is an emerging cancer treatment drug. The original drug has not yet been marketed in China, so it cannot be included in medical insurance. The price of Avelumab's generic drug, 200mg/10mL per box, may be more than RMB 10,000 per box (the price may fluctuate due to the exchange rate). We are not aware of any Avelumab generics being produced and put on the market. For specific prices and drug details, please consult Yade's medical consultant.